Osimertinib drugs market to reach $16.25 billion by 2030 at 16.1% cagr, driven by increasing incidence of lung cancer and rising organizational initiatives to improve cancer care.
Read More
Global Neurotechnology market size is expected to reach $33.64 billion by 2030 at 14.1%, neurological conditions’ surge catalyst for neurotechnology market expansion
Read More
Orphan drugs service market to reach $93.93 billion by 2030 at 16.6% cagr, driven by growing investment in rare diseases and increased funding for research and development.
Read More
Global Neuroscience market size is expected to reach $54.01 billion by 2030 at 7.6%, surging geriatric demographics fueling growth in the neuroscience market
Read More
Orphan drugs market to reach $794.12 billion by 2030 at 28.2% cagr, driven by rising prevalence of rare diseases globally and increasing diagnosis rates.
Read More
Global Neuroprosthetics market size is expected to reach $23.1 billion by 2030 at 14.6%, neuroprosthetics market soars as global neurological disorder and nerve injury cases surge
Read More
Organic pharmaceutical excipients market to reach $18.99 billion by 2030 at 9.3% cagr, driven by rising demand for pharmaceutical drugs due to growing burden of chronic and complex health conditions.
Read More
Global Neuroplasticity market size is expected to reach $18.48 by 2030 at 22.9%, rising burden of neurological disorders fueling the growth of the market due to increasing demand for advanced brain therapies
Read More
Organ transplant immunosuppressant drugs market to reach $6.85 billion by 2030 at 4.8% cagr, driven by increasing demand for organ transplantation.
Read More
Global Neurotrophic Keratitis Treatment market size is expected to reach $8.48 billion by 2030 at 8.1%, segmented as by topical antibiotics, broad-spectrum antibiotics, narrow-spectrum antibiotics
Read More